Skip to content

Total debt at other companies

AngioDynamics logo
AngioDynamicsANGO
$7.9M+10.2%
Delcath Systems logo
Delcath SystemsDCTH
$907K-10.7%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$15.17M-62.7%
LQD
Liquidia CorporationLQDA
$6.96M+1.5%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.38M+29.5%
Novanta logo
NovantaNOVT
$291.34M-34.2%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Calculated from TriSalus Life Sciences, Inc.’s reported figures.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s total debt?
TriSalus Life Sciences, Inc. (TLSI) reported total debt of $33.08M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s total debt changed year-over-year?
TriSalus Life Sciences, Inc.'s total debt increased by 4.4% year-over-year, from $31.7M to $33.08M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s total debt?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s total debt has grown at a 364.7% compound annual growth rate (CAGR), from $1.6M to $34.44M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.